Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC
- 17 October 2025
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 84 (4) , 808-822
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Municipal Science and Technology Project (2024A04J5065)
- Postdoctoral Research Foundation of China (2022M720909)
- Guangzhou Medical University (2021113084)
- Second Affiliated Hospital of Guangzhou Medical University
- National Natural Science Foundation of China (82172043)
- National Natural Science Foundation of China (82001929)
- National Natural Science Foundation of China (U23A2096)
- National Natural Science Foundation of China (82402405)
- National Natural Science Foundation of China (82302326)
This publication has 31 references indexed in Scilit:
- Survival in Patients With Recurrent Intermediate-Stage Hepatocellular CarcinomaJAMA Oncology, 2024
- The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinomaHepatology, 2023
- CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicasActas Dermo-Sifiliograficas, 2021
- Hsp90 chaperones have an energetic hot‐spot for binding inhibitorsProtein Science, 2020
- Gut Microbiota Regulation of Tryptophan Metabolism in Health and DiseaseCell Host & Microbe, 2018
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety dataHepatology, 2016
- Macrophage heterogeneity in liver injury and fibrosisJournal of Hepatology, 2014
- Modulation of the fecal bile acid profile by gut microbiota in cirrhosisJournal of Hepatology, 2013
- Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beadsJournal of Hepatology, 2012
- Characterization of fecal microbial communities in patients with liver cirrhosisHepatology, 2011